Share Price and Basic Stock Data
Last Updated: October 22, 2025, 5:27 am
| PEG Ratio | -30.46 |
|---|
Analyst Insight & Comprehensive Analysis
Business Overview and Revenue Trends
A-1 Acid Ltd operates within the chemicals sector, specifically focusing on inorganic chemicals. As of the latest reporting, the company’s stock price stood at ₹982, with a market capitalization of ₹1,129 Cr. The revenue from operations reported for the fiscal year ending March 2025 was ₹331 Cr, consistent with the previous year’s revenue. However, the quarterly performance indicates a decline in sales, notably from ₹93.84 Cr in June 2022 to ₹47.20 Cr in September 2023, reflecting a downward trend. The operating profit margin (OPM) has fluctuated significantly over the same period, registering a negative OPM of -0.36% in June 2023 and recovering slightly to 2.80% in December 2023. This inconsistent revenue pattern raises concerns about the company’s ability to maintain stable cash flows, which is critical for operations in a competitive industry. Overall, the revenue trajectory suggests challenges that need to be addressed to ensure long-term viability in the market.
Profitability and Efficiency Metrics
The profitability metrics of A-1 Acid Ltd reveal a mixed performance. The return on equity (ROE) is reported at 7.82%, while the return on capital employed (ROCE) stands at 10.6%. These figures indicate that the company is generating returns on its equity and capital, but the margins are relatively low compared to industry standards. The operating profit for the fiscal year ending March 2025 is projected at ₹10 Cr, up from ₹4 Cr in the previous year, suggesting potential recovery. However, the company has experienced negative operating profits in several quarters, with the most significant drop recorded at -0.37 Cr in March 2023. The interest coverage ratio (ICR) is a robust 8.50x, indicating that the company can comfortably meet its interest obligations. The cash conversion cycle stands at 57 days, which is on the higher side, suggesting that the company may be facing challenges in efficiently managing its working capital and inventory.
Balance Sheet Strength and Financial Ratios
A-1 Acid Ltd maintains a relatively stable balance sheet, with total borrowings reported at ₹22 Cr against reserves of ₹38 Cr. This results in a debt-to-equity ratio of 0.22, indicating a conservative approach to leveraging. The current ratio of 3.48x and quick ratio of 3.33x reflect strong liquidity, suggesting that the company has adequate short-term assets to cover its liabilities. However, the price-to-book value (P/BV) ratio is notably high at 8.29x, which may imply that the stock is overvalued compared to its book value. The efficiency ratios indicate a cash conversion cycle of 57 days, which, while manageable, could be improved to enhance operational efficiency. The company’s ability to generate cash flow from its operations remains a critical factor for sustaining its financial health, especially in light of fluctuating sales and profitability.
Shareholding Pattern and Investor Confidence
The shareholding pattern of A-1 Acid Ltd indicates a strong promoter holding of 70.03%, reflecting confidence from the founders in the company’s long-term prospects. Foreign institutional investors (FIIs) have gradually increased their stake from 2.85% in March 2023 to 5.80% in June 2025, which may signal growing interest from international investors. However, the public shareholding has seen a decline from 30% in September 2022 to 24.17% in June 2025, raising questions about retail investor sentiment. The company had 1,802 shareholders as of June 2025, down from a peak of 2,106 in June 2023, indicating potential concerns among investors regarding the company’s performance and future outlook. This trend may impact market liquidity and the stock’s volatility, which are critical for attracting new investors.
Outlook, Risks, and Final Insight
If margins sustain their recovery, A-1 Acid Ltd could see improved profitability, especially if it can stabilize its revenue streams and manage costs effectively. However, risks such as declining sales, fluctuating operating profits, and high valuation metrics may pose challenges. The company needs to address operational inefficiencies and enhance its cash flow management to navigate the competitive landscape effectively. Moreover, the dependence on promoter holdings and the declining public interest could affect stock market performance. Strengthening operational metrics and bolstering investor confidence will be vital for A-1 Acid Ltd to achieve sustainable growth in a challenging industry environment.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of A-1 Acid Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Fischer Medical Ventures Ltd | 6,475 Cr. | 99.8 | 125/60.0 | 980 | 5.29 | 0.01 % | 1.08 % | 0.70 % | 1.00 |
| Emmessar Biotech & Nutrition Ltd | 15.4 Cr. | 30.9 | 64.0/25.8 | 38.6 | 15.4 | 0.00 % | 12.6 % | 4.23 % | 10.0 |
| Cochin Minerals & Rutile Ltd | 231 Cr. | 295 | 415/238 | 11.1 | 211 | 2.71 % | 23.3 % | 15.0 % | 10.0 |
| Archean Chemical Industries Ltd | 8,058 Cr. | 653 | 730/408 | 36.5 | 152 | 0.46 % | 16.0 % | 12.0 % | 2.00 |
| Alufluoride Ltd | 354 Cr. | 452 | 544/341 | 17.2 | 144 | 0.66 % | 23.6 % | 20.8 % | 10.0 |
| Industry Average | 5,588.50 Cr | 508.87 | 156.39 | 153.36 | 0.45% | 13.95% | 10.65% | 7.00 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 93.84 | 86.11 | 79.03 | 71.62 | 58.97 | 47.20 | 41.76 | 61.04 | 70.71 | 77.76 | 74.33 | 109.62 | 64.69 |
| Expenses | 91.32 | 85.10 | 77.95 | 71.99 | 59.18 | 47.31 | 40.59 | 58.79 | 68.69 | 75.26 | 71.50 | 107.19 | 62.83 |
| Operating Profit | 2.52 | 1.01 | 1.08 | -0.37 | -0.21 | -0.11 | 1.17 | 2.25 | 2.02 | 2.50 | 2.83 | 2.43 | 1.86 |
| OPM % | 2.69% | 1.17% | 1.37% | -0.52% | -0.36% | -0.23% | 2.80% | 3.69% | 2.86% | 3.22% | 3.81% | 2.22% | 2.88% |
| Other Income | 2.18 | 0.41 | 0.80 | 2.96 | 1.61 | 1.15 | 0.39 | -0.19 | 0.24 | 0.07 | 0.11 | 0.05 | 0.09 |
| Interest | 0.47 | 0.35 | 0.54 | 0.47 | 0.22 | 0.15 | 0.13 | 0.26 | 0.26 | 0.34 | 0.68 | 0.38 | 0.42 |
| Depreciation | 1.05 | 0.96 | 1.03 | 0.96 | 0.89 | 0.90 | 0.90 | 0.90 | 0.88 | 0.89 | 0.90 | 0.92 | 0.69 |
| Profit before tax | 3.18 | 0.11 | 0.31 | 1.16 | 0.29 | -0.01 | 0.53 | 0.90 | 1.12 | 1.34 | 1.36 | 1.18 | 0.84 |
| Tax % | 26.42% | 90.91% | 41.94% | 6.90% | 37.93% | 300.00% | 60.38% | 17.78% | 25.00% | 27.61% | 26.47% | 27.97% | 28.57% |
| Net Profit | 2.34 | 0.02 | 0.19 | 1.07 | 0.18 | -0.04 | 0.21 | 0.75 | 0.84 | 0.97 | 1.00 | 0.84 | 0.60 |
| EPS in Rs | 2.03 | 0.02 | 0.17 | 0.93 | 0.16 | -0.03 | 0.18 | 0.65 | 0.73 | 0.84 | 0.87 | 0.73 | 0.52 |
Last Updated: August 20, 2025, 12:55 am
Below is a detailed analysis of the quarterly data for A-1 Acid Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 64.69 Cr.. The value appears to be declining and may need further review. It has decreased from 109.62 Cr. (Mar 2025) to 64.69 Cr., marking a decrease of 44.93 Cr..
- For Expenses, as of Jun 2025, the value is 62.83 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 107.19 Cr. (Mar 2025) to 62.83 Cr., marking a decrease of 44.36 Cr..
- For Operating Profit, as of Jun 2025, the value is 1.86 Cr.. The value appears to be declining and may need further review. It has decreased from 2.43 Cr. (Mar 2025) to 1.86 Cr., marking a decrease of 0.57 Cr..
- For OPM %, as of Jun 2025, the value is 2.88%. The value appears strong and on an upward trend. It has increased from 2.22% (Mar 2025) to 2.88%, marking an increase of 0.66%.
- For Other Income, as of Jun 2025, the value is 0.09 Cr.. The value appears strong and on an upward trend. It has increased from 0.05 Cr. (Mar 2025) to 0.09 Cr., marking an increase of 0.04 Cr..
- For Interest, as of Jun 2025, the value is 0.42 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.38 Cr. (Mar 2025) to 0.42 Cr., marking an increase of 0.04 Cr..
- For Depreciation, as of Jun 2025, the value is 0.69 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.92 Cr. (Mar 2025) to 0.69 Cr., marking a decrease of 0.23 Cr..
- For Profit before tax, as of Jun 2025, the value is 0.84 Cr.. The value appears to be declining and may need further review. It has decreased from 1.18 Cr. (Mar 2025) to 0.84 Cr., marking a decrease of 0.34 Cr..
- For Tax %, as of Jun 2025, the value is 28.57%. The value appears to be increasing, which may not be favorable. It has increased from 27.97% (Mar 2025) to 28.57%, marking an increase of 0.60%.
- For Net Profit, as of Jun 2025, the value is 0.60 Cr.. The value appears to be declining and may need further review. It has decreased from 0.84 Cr. (Mar 2025) to 0.60 Cr., marking a decrease of 0.24 Cr..
- For EPS in Rs, as of Jun 2025, the value is 0.52. The value appears to be declining and may need further review. It has decreased from 0.73 (Mar 2025) to 0.52, marking a decrease of 0.21.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: October 15, 2025, 4:06 am
| Metric | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 97 | 85 | 106 | 100 | 141 | 116 | 145 | 310 | 331 | 211 | 331 | 326 |
| Expenses | 93 | 82 | 99 | 104 | 143 | 112 | 141 | 301 | 326 | 206 | 321 | 317 |
| Operating Profit | 3 | 3 | 7 | -4 | -2 | 4 | 4 | 9 | 4 | 5 | 10 | 10 |
| OPM % | 4% | 4% | 6% | -4% | -2% | 3% | 3% | 3% | 1% | 2% | 3% | 3% |
| Other Income | 0 | 0 | 0 | 11 | 9 | 4 | 4 | 4 | 6 | 2 | 0 | 0 |
| Interest | 2 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 2 | 1 | 2 | 2 |
| Depreciation | 2 | 1 | 1 | 2 | 0 | 3 | 3 | 3 | 4 | 4 | 4 | 3 |
| Profit before tax | 0 | 1 | 4 | 4 | 6 | 4 | 4 | 8 | 5 | 2 | 5 | 5 |
| Tax % | 25% | 26% | 33% | 49% | 25% | 24% | 34% | 26% | 24% | 36% | 27% | |
| Net Profit | 0 | 1 | 3 | 2 | 4 | 3 | 3 | 6 | 4 | 1 | 4 | 3 |
| EPS in Rs | 1.08 | 7.67 | 25.00 | 2.37 | 3.63 | 2.77 | 2.37 | 5.49 | 3.14 | 0.96 | 3.17 | 2.96 |
| Dividend Payout % | 0% | 16% | 0% | 0% | 0% | 0% | 0% | 27% | 48% | 157% | 47% |
YoY Net Profit Growth
| Year | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 200.00% | -33.33% | 100.00% | -25.00% | 0.00% | 100.00% | -33.33% | -75.00% | 300.00% |
| Change in YoY Net Profit Growth (%) | 0.00% | -233.33% | 133.33% | -125.00% | 25.00% | 100.00% | -133.33% | -41.67% | 375.00% |
A-1 Acid Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 9 years from 2016-2017 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 13% |
| 5 Years: | 23% |
| 3 Years: | 2% |
| TTM: | 48% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 37% |
| 5 Years: | 4% |
| 3 Years: | -16% |
| TTM: | 94% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | 79% |
| 3 Years: | 42% |
| 1 Year: | 173% |
| Return on Equity | |
|---|---|
| 10 Years: | 10% |
| 5 Years: | 8% |
| 3 Years: | 6% |
| Last Year: | 8% |
Last Updated: September 5, 2025, 2:01 pm
Balance Sheet
Last Updated: September 10, 2025, 2:52 pm
| Month | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 1 | 1 | 1 | 7 | 10 | 10 | 10 | 12 | 12 | 12 | 12 |
| Reserves | 7 | 7 | 10 | 7 | 25 | 27 | 30 | 35 | 37 | 36 | 38 |
| Borrowings | 13 | 12 | 19 | 16 | 15 | 6 | 17 | 26 | 14 | 11 | 22 |
| Other Liabilities | 3 | 6 | 8 | 8 | 4 | 4 | 4 | 7 | 5 | 3 | 2 |
| Total Liabilities | 24 | 26 | 38 | 39 | 53 | 48 | 61 | 80 | 68 | 61 | 74 |
| Fixed Assets | 4 | 3 | 11 | 9 | 14 | 11 | 14 | 17 | 16 | 13 | 11 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 3 | 5 | 5 |
| Other Assets | 20 | 23 | 26 | 30 | 38 | 37 | 47 | 60 | 48 | 43 | 58 |
| Total Assets | 24 | 26 | 38 | 39 | 53 | 48 | 61 | 80 | 68 | 61 | 74 |
Below is a detailed analysis of the balance sheet data for A-1 Acid Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Equity Capital, as of Mar 2025, the value is 12.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 12.00 Cr..
- For Reserves, as of Mar 2025, the value is 38.00 Cr.. The value appears strong and on an upward trend. It has increased from 36.00 Cr. (Mar 2024) to 38.00 Cr., marking an increase of 2.00 Cr..
- For Borrowings, as of Mar 2025, the value is 22.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 11.00 Cr. (Mar 2024) to 22.00 Cr., marking an increase of 11.00 Cr..
- For Other Liabilities, as of Mar 2025, the value is 2.00 Cr.. The value appears to be improving (decreasing). It has decreased from 3.00 Cr. (Mar 2024) to 2.00 Cr., marking a decrease of 1.00 Cr..
- For Total Liabilities, as of Mar 2025, the value is 74.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 61.00 Cr. (Mar 2024) to 74.00 Cr., marking an increase of 13.00 Cr..
- For Fixed Assets, as of Mar 2025, the value is 11.00 Cr.. The value appears to be declining and may need further review. It has decreased from 13.00 Cr. (Mar 2024) to 11.00 Cr., marking a decrease of 2.00 Cr..
- For CWIP, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
- For Investments, as of Mar 2025, the value is 5.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 5.00 Cr..
- For Other Assets, as of Mar 2025, the value is 58.00 Cr.. The value appears strong and on an upward trend. It has increased from 43.00 Cr. (Mar 2024) to 58.00 Cr., marking an increase of 15.00 Cr..
- For Total Assets, as of Mar 2025, the value is 74.00 Cr.. The value appears strong and on an upward trend. It has increased from 61.00 Cr. (Mar 2024) to 74.00 Cr., marking an increase of 13.00 Cr..
Notably, the Reserves (38.00 Cr.) exceed the Borrowings (22.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -10.00 | -9.00 | -12.00 | -20.00 | -17.00 | -2.00 | -13.00 | -17.00 | -10.00 | -6.00 | -12.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 69 | 87 | 76 | 89 | 70 | 78 | 91 | 54 | 42 | 53 | 56 |
| Inventory Days | 3 | 7 | 2 | 4 | 2 | 4 | 6 | 3 | 2 | 4 | 3 |
| Days Payable | 3 | 8 | 5 | 14 | 4 | 1 | 4 | 4 | 1 | 3 | 2 |
| Cash Conversion Cycle | 70 | 86 | 73 | 80 | 68 | 81 | 93 | 54 | 43 | 54 | 57 |
| Working Capital Days | 16 | 22 | 17 | 32 | 64 | 83 | 69 | 33 | 31 | 41 | 35 |
| ROCE % | 13% | 23% | 18% | 17% | 11% | 9% | 15% | 10% | 4% | 11% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 0.95 | 3.14 | 5.48 | 2.37 |
| Diluted EPS (Rs.) | 0.95 | 3.14 | 5.48 | 2.37 |
| Cash EPS (Rs.) | 4.41 | 6.67 | 8.52 | 5.54 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 41.54 | 42.09 | 40.45 | 40.21 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 41.54 | 42.09 | 40.45 | 40.21 |
| Revenue From Operations / Share (Rs.) | 179.25 | 287.48 | 269.88 | 145.18 |
| PBDIT / Share (Rs.) | 5.60 | 9.27 | 11.46 | 7.68 |
| PBIT / Share (Rs.) | 2.48 | 5.79 | 8.55 | 4.88 |
| PBT / Share (Rs.) | 1.82 | 4.19 | 7.50 | 4.15 |
| Net Profit / Share (Rs.) | 1.28 | 3.19 | 5.61 | 2.73 |
| NP After MI And SOA / Share (Rs.) | 0.95 | 3.14 | 5.48 | 2.73 |
| PBDIT Margin (%) | 3.12 | 3.22 | 4.24 | 5.29 |
| PBIT Margin (%) | 1.38 | 2.01 | 3.16 | 3.35 |
| PBT Margin (%) | 1.01 | 1.45 | 2.78 | 2.86 |
| Net Profit Margin (%) | 0.71 | 1.11 | 2.07 | 1.88 |
| NP After MI And SOA Margin (%) | 0.53 | 1.09 | 2.03 | 1.88 |
| Return on Networth / Equity (%) | 2.29 | 7.46 | 13.55 | 6.79 |
| Return on Capital Employeed (%) | 5.57 | 12.45 | 18.76 | 10.97 |
| Return On Assets (%) | 1.72 | 5.33 | 7.91 | 4.47 |
| Long Term Debt / Equity (X) | 0.05 | 0.09 | 0.11 | 0.09 |
| Total Debt / Equity (X) | 0.22 | 0.29 | 0.55 | 0.41 |
| Asset Turnover Ratio (%) | 3.14 | 4.48 | 4.41 | 0.00 |
| Current Ratio (X) | 3.48 | 3.20 | 2.03 | 2.67 |
| Quick Ratio (X) | 3.33 | 3.11 | 1.94 | 2.56 |
| Interest Coverage Ratio (X) | 8.50 | 5.81 | 10.93 | 10.66 |
| Interest Coverage Ratio (Post Tax) (X) | 2.94 | 3.00 | 6.35 | 4.79 |
| Enterprise Value (Cr.) | 399.87 | 401.40 | 325.92 | 115.99 |
| EV / Net Operating Revenue (X) | 1.94 | 1.21 | 1.05 | 0.79 |
| EV / EBITDA (X) | 62.10 | 37.67 | 24.72 | 15.10 |
| MarketCap / Net Operating Revenue (X) | 1.92 | 1.18 | 0.96 | 0.68 |
| Price / BV (X) | 8.29 | 8.07 | 6.45 | 2.48 |
| Price / Net Operating Revenue (X) | 1.92 | 1.18 | 0.96 | 0.68 |
| EarningsYield | 0.00 | 0.01 | 0.02 | 0.02 |
After reviewing the key financial ratios for A-1 Acid Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 24, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 24, the value is 0.95. This value is below the healthy minimum of 5. It has decreased from 3.14 (Mar 23) to 0.95, marking a decrease of 2.19.
- For Diluted EPS (Rs.), as of Mar 24, the value is 0.95. This value is below the healthy minimum of 5. It has decreased from 3.14 (Mar 23) to 0.95, marking a decrease of 2.19.
- For Cash EPS (Rs.), as of Mar 24, the value is 4.41. This value is within the healthy range. It has decreased from 6.67 (Mar 23) to 4.41, marking a decrease of 2.26.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 41.54. It has decreased from 42.09 (Mar 23) to 41.54, marking a decrease of 0.55.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 41.54. It has decreased from 42.09 (Mar 23) to 41.54, marking a decrease of 0.55.
- For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 179.25. It has decreased from 287.48 (Mar 23) to 179.25, marking a decrease of 108.23.
- For PBDIT / Share (Rs.), as of Mar 24, the value is 5.60. This value is within the healthy range. It has decreased from 9.27 (Mar 23) to 5.60, marking a decrease of 3.67.
- For PBIT / Share (Rs.), as of Mar 24, the value is 2.48. This value is within the healthy range. It has decreased from 5.79 (Mar 23) to 2.48, marking a decrease of 3.31.
- For PBT / Share (Rs.), as of Mar 24, the value is 1.82. This value is within the healthy range. It has decreased from 4.19 (Mar 23) to 1.82, marking a decrease of 2.37.
- For Net Profit / Share (Rs.), as of Mar 24, the value is 1.28. This value is below the healthy minimum of 2. It has decreased from 3.19 (Mar 23) to 1.28, marking a decrease of 1.91.
- For NP After MI And SOA / Share (Rs.), as of Mar 24, the value is 0.95. This value is below the healthy minimum of 2. It has decreased from 3.14 (Mar 23) to 0.95, marking a decrease of 2.19.
- For PBDIT Margin (%), as of Mar 24, the value is 3.12. This value is below the healthy minimum of 10. It has decreased from 3.22 (Mar 23) to 3.12, marking a decrease of 0.10.
- For PBIT Margin (%), as of Mar 24, the value is 1.38. This value is below the healthy minimum of 10. It has decreased from 2.01 (Mar 23) to 1.38, marking a decrease of 0.63.
- For PBT Margin (%), as of Mar 24, the value is 1.01. This value is below the healthy minimum of 10. It has decreased from 1.45 (Mar 23) to 1.01, marking a decrease of 0.44.
- For Net Profit Margin (%), as of Mar 24, the value is 0.71. This value is below the healthy minimum of 5. It has decreased from 1.11 (Mar 23) to 0.71, marking a decrease of 0.40.
- For NP After MI And SOA Margin (%), as of Mar 24, the value is 0.53. This value is below the healthy minimum of 8. It has decreased from 1.09 (Mar 23) to 0.53, marking a decrease of 0.56.
- For Return on Networth / Equity (%), as of Mar 24, the value is 2.29. This value is below the healthy minimum of 15. It has decreased from 7.46 (Mar 23) to 2.29, marking a decrease of 5.17.
- For Return on Capital Employeed (%), as of Mar 24, the value is 5.57. This value is below the healthy minimum of 10. It has decreased from 12.45 (Mar 23) to 5.57, marking a decrease of 6.88.
- For Return On Assets (%), as of Mar 24, the value is 1.72. This value is below the healthy minimum of 5. It has decreased from 5.33 (Mar 23) to 1.72, marking a decrease of 3.61.
- For Long Term Debt / Equity (X), as of Mar 24, the value is 0.05. This value is below the healthy minimum of 0.2. It has decreased from 0.09 (Mar 23) to 0.05, marking a decrease of 0.04.
- For Total Debt / Equity (X), as of Mar 24, the value is 0.22. This value is within the healthy range. It has decreased from 0.29 (Mar 23) to 0.22, marking a decrease of 0.07.
- For Asset Turnover Ratio (%), as of Mar 24, the value is 3.14. It has decreased from 4.48 (Mar 23) to 3.14, marking a decrease of 1.34.
- For Current Ratio (X), as of Mar 24, the value is 3.48. This value exceeds the healthy maximum of 3. It has increased from 3.20 (Mar 23) to 3.48, marking an increase of 0.28.
- For Quick Ratio (X), as of Mar 24, the value is 3.33. This value exceeds the healthy maximum of 2. It has increased from 3.11 (Mar 23) to 3.33, marking an increase of 0.22.
- For Interest Coverage Ratio (X), as of Mar 24, the value is 8.50. This value is within the healthy range. It has increased from 5.81 (Mar 23) to 8.50, marking an increase of 2.69.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 2.94. This value is below the healthy minimum of 3. It has decreased from 3.00 (Mar 23) to 2.94, marking a decrease of 0.06.
- For Enterprise Value (Cr.), as of Mar 24, the value is 399.87. It has decreased from 401.40 (Mar 23) to 399.87, marking a decrease of 1.53.
- For EV / Net Operating Revenue (X), as of Mar 24, the value is 1.94. This value is within the healthy range. It has increased from 1.21 (Mar 23) to 1.94, marking an increase of 0.73.
- For EV / EBITDA (X), as of Mar 24, the value is 62.10. This value exceeds the healthy maximum of 15. It has increased from 37.67 (Mar 23) to 62.10, marking an increase of 24.43.
- For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 1.92. This value is within the healthy range. It has increased from 1.18 (Mar 23) to 1.92, marking an increase of 0.74.
- For Price / BV (X), as of Mar 24, the value is 8.29. This value exceeds the healthy maximum of 3. It has increased from 8.07 (Mar 23) to 8.29, marking an increase of 0.22.
- For Price / Net Operating Revenue (X), as of Mar 24, the value is 1.92. This value is within the healthy range. It has increased from 1.18 (Mar 23) to 1.92, marking an increase of 0.74.
- For EarningsYield, as of Mar 24, the value is 0.00. This value is below the healthy minimum of 5. It has decreased from 0.01 (Mar 23) to 0.00, marking a decrease of 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in A-1 Acid Ltd:
- Net Profit Margin: 0.71%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 5.57% (Industry Average ROCE: 13.95%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 2.29% (Industry Average ROE: 10.65%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 2.94
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 3.33
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 354 (Industry average Stock P/E: 156.39)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.22
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 0.71%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Chemicals - Inorganic - Others | Corporate House No. A-1, Shivalik Business Centre, Ahmedabad Gujarat 380059 | info@a1acid.com http://www.a-1limited.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Harshadkumar Naranbhai Patel | Chairman & Managing Director |
| Mr. Jitendra Naranbhai Patel | Whole Time Director |
| Mr. Utkarsh Harshadkumar Patel | Whole Time Director |
| Mrs. Krishna Utkarsh Patel | Non Executive Director |
| Mr. Anant Jitendra Patel | Non Executive Director |
| Mrs. Lajju Hemang Shah | Independent Director |
| Mr. Chirag Rajnikant Shah | Independent Director |
| Mr. Nitin Rikhavbhai Shah | Independent Director |
| Mr. Suresh Somnath Dave | Independent Director |
| Mr. Shailesh Natverlal Thakkar | Independent Director |
FAQ
What is the intrinsic value of A-1 Acid Ltd?
A-1 Acid Ltd's intrinsic value (as of 23 October 2025) is 958.06 which is 8.84% lower the current market price of 1,051.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 1,209 Cr. market cap, FY2025-2026 high/low of 1,055/304, reserves of ₹38 Cr, and liabilities of 74 Cr.
What is the Market Cap of A-1 Acid Ltd?
The Market Cap of A-1 Acid Ltd is 1,209 Cr..
What is the current Stock Price of A-1 Acid Ltd as on 23 October 2025?
The current stock price of A-1 Acid Ltd as on 23 October 2025 is 1,051.
What is the High / Low of A-1 Acid Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of A-1 Acid Ltd stocks is 1,055/304.
What is the Stock P/E of A-1 Acid Ltd?
The Stock P/E of A-1 Acid Ltd is 354.
What is the Book Value of A-1 Acid Ltd?
The Book Value of A-1 Acid Ltd is 43.2.
What is the Dividend Yield of A-1 Acid Ltd?
The Dividend Yield of A-1 Acid Ltd is 0.14 %.
What is the ROCE of A-1 Acid Ltd?
The ROCE of A-1 Acid Ltd is 10.6 %.
What is the ROE of A-1 Acid Ltd?
The ROE of A-1 Acid Ltd is 7.82 %.
What is the Face Value of A-1 Acid Ltd?
The Face Value of A-1 Acid Ltd is 10.0.